Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sanofi S.r.l. | Anagni, Italy | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 29, 2024 · 7 inspections |
| Sanofi Winthrop Industrie | Aramon, France | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 10, 2023 · 6 inspections |
Recalls
- Aug 10, 2020 · Class II · Sanofi-Aventis U.S. LLC
Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
Lots: Lot #: A9306, Exp 2/28/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Rasburicase: every company that makes it
- Form
- kit
- Strength
- 7.5 mg per 5 mL
- Approval
- BLA BLA103946
- On the market since
- Jun 1, 2006
- Package NDCs
0024-5151-750024-5153-740024-5155-74- Official label
- DailyMed (National Library of Medicine), updated Jul 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?